Skip to main content
. Author manuscript; available in PMC: 2016 Jun 24.
Published in final edited form as: Adv Healthc Mater. 2015 Apr 30;4(9):1376–1385. doi: 10.1002/adhm.201400766

Table 1. Compositions of Magnetically Purified Composite NanoCarriers (CNCs) a.

Co-Core Excipient Globule Size (d-nm) Purified CNC Composition Relative Number Density WRT IONC Yield (wt %)
IONC (wt %) Co-Core Excipient (wt %) Stabilizer (wt %)
Original Formulation - 8 42 50 - -
Hostasol Yellow 1 25 ± 4.8 45.6 ± 1.6 29.5 ± 3.2 15,000 28.4 ± 1.3
11k PLA 4 22.0 ± 0.9 49.2 ± 1.5 31.0 ± 0.7 800 31.7 ± 0.5
106k PLA 9 15.0 ± 1.1 61.3 ± 1.3 25.5 ± 2.5 80 42.1 ± 0.9
a

CNCs were prepared from initial formulations comprising 50 wt% PEG-b-PLA, 8 wt% IONC, and 42 wt% core co-excipient.